2. Outline
Disease Burden of Toxoplasmosis in
India
The Test Formats available
Antibody Detection
Detection of Toxoplasma- Microscopy, Animal, Culture
Detection of Parasite DNA
Application in Clinical Situations
Screening in Pregnancy
Diagnosis in the Neonatal, pre natal stage
Diagnosis in immunocompromised host- Cerebral
Toxoplasmosis
3. The Disease Burden
In India, the national seroprevalence
has been found to be 24.3%.(Dhumne et
al,2007. J Parasitol;93)
Lowest in the northern parts of India,
and highest in the south.
A high seroprevalence of 57% has been
reported from Almora district (Singh and
Nautiyal 1991. IJMR;93)
A recent study from Chandigarh: 15.33%
pregnant women were
seropositive.(Khurana et al 2010. IJMM;28).
4. The Disease Burden
Study from Hyderabad showed a
seropositivity (IgG) rate of 27% in
women with BOH, and IgM in 11.5%.
Study from our centre revealed 9.3%
IgM positivity rate in BOH cases.
5. The Test Formats:1. Antibody
Remains the test method of choice.
1.
Use of Particulate Antigens:
Trophozoites, IgG
2.
Dye Test
IFAT
Agglutination, Differential Agglutination.
Use of Soluble Antigens: Cytosol
antigen.
ELISA
Avidity Test
Western Blot
6. 1. Antibody Detection
a.
Sabin Feldman Dye Test : IgG
Described in 1948 (Science, 1948:108)
Cytotoxic effect of antibodies in the
presence of complements.
End point is the dilution at which 50%
of the tachyzoites are dead.
Live tachyzoites necessary
Easy to read, Highly sensitive (2 IU/ml)
Detects very early antibodies.
7. 1. Antibody Detection
b. IFAT:
Formalin treated tachyzoites used
Can detect IgG, IgM
Difficult to interpret
BFP in autoimmune diseases.
8. 1. Antibody Detection
c. Agglutination Test: IgG
Formalin treated antigen
Highly sensitive if 2ME treatment is
done.
Differential Agglutination Test :
Formalin treated antigen(HS) and
methanol treated antigen (AC) used
with a single sample
To rule out recent infection.
9. 1. Antibody Detection
AC
antigen specific for membrane,
strong antibody response in early
infection, wanes after 6-12 mts.
Sensitivity: HS: 2 IU/ml, AC: 50IU/ml
HS/AC≥ 4 : Infection has occurred
more than 6 months before.
Antigens difficult to prepare, not
available commercially.
10. 1. Antibody Detection
Use of Soluble antigen: Cytosol
antigens enriched with membrane
antigen( P30, SAG 1) to enhance
sensitivity.
a. ELISA
Extensively used
IgG, IgM, IgA, IgE.
IgG indirect ELISA: Sensitivity 10300 IU/ml.
11. 1. Antibody Detection
b. IgG Avidity Test
Increasing humoral response, ↑avidity of IgG
Early stage of infection: Weak avidity; late
stage: Strong avidity
Two parallel ELISA: Untreated serum; serum
treated with urea/guanidine/thiocyanate
(Dissociates Ag-Ab complex of weak avidity)
High avidity index→ Infection in remote past
Caveat: Not always true, ↑in avidity may be
slow
12. 1. Antibody Detection
c. Western Blot Test
Two samples tested in parallel:
Blood/CSF; Blood/aqueous humor;
Maternal/neonatal blood.
Additional bands in the second
sample denotes organ/neonatal
infection
13. IgG and IgM Western blots of
serum from a mother (m)
and her newborn (b). Sera
were drawn from mother and
baby when the baby was 2
days of age.
Toxoplasmawas isolated from
the placental tissue.
Remington et al 2004.
JCM:42.
14. 2. Detection of Toxoplasma
a.
Microscopy:
Smears stained by Giemsa, FAT,
Biopsy material
Presence of foci of tacyzoites with or
without cysts suggest active disease.
15. 2. Detection of Toxoplasma
b. Animal Inoculation
Body fluids, trypsinized tissue
Intraperitoneal inoculation in 6-8 mice
Seroconversion occurs after 7-10
days
Peritoneal lavage examination shows
the tachyzoites.
16. 2. Detection of Toxoplasma
c. Cell Culture:
Human embryo fibroblast (MRC5) or
monocyte lines (THP 1).
4-5 days.
17. 3. PCR
Diagnosis of congenital, ocular, cerebral
toxoplasmosis.
The most common use of PCR is for
prenatal diagnosis of the congenital
infection using amniotic fluid.
Most laboratories use the 35-foldrepeated B1 gene
Some laboratories in Europe are
switching to the AF146527 sequence, a
DNA fragment that is repeated 200- to
300-fold in the T. gondii genome.
18. 3. PCR
An evaluation of three targets (18S
ribosomal DNA, B1, and AF146527) in
parallel.
Differences in the sensitivity and
specificity of these three PCR
techniques were not found to be
statistically significant ( Filisetti et al 2003.
JCM;41).
19. Diagnosis in Pregnancy
Active infection normally occur once
in life.
Acquired immunity is life long
The risk is only from an infection
caught for the first time during
pregnancy, or 2-3 months before
conception.
Mothers who tested positive before
the pregnancy do not need
monitoring/screening.
20. Diagnosis in Pregnancy
Within 2–3 months before conception
- 1% or below risk of transmission but
a high risk of miscarriage
• Severity varies with age of fetus
• More severe manifestation early in
pregnancy, Less frequent transmission
• More frequent transmission later in
pregnancy, Less severe manifestation
22. Diagnosis in Pregnancy
In most centres one sample is tested
for IgG and/or IgM
IgM
◦ Determine recent infection or in the distant past.
◦ Significant potential of misinterpretation of +ve
result, should be confirmed by other tests.
◦ IgM antibodies can persist for months to more
than one year.
◦ Persistence of these IgM antibodies does not
appear to have any clinical relevance .
24. Neonatal/Prenatal Diagnosis
Diagnosis in neonatal period : WBT
with paired sample
IgM and IgA detection may be used:
Chance of false negative because of
small amounts produced.
Declining IgG level may be used to
rule out congenital infection.
PCR of amniotic fluid+
Ultrasonogram done after 18 weeks.
25. Diagnosis in
Immunocompromised Patients
Peripheral blood, BAL, Bone marrow
may be used to demonstrate and/or
isolate the parasite.
PCR with the above samples.
If IgG in blood is positive, risk is high
in HIV positive patients with CD4+
count<200/cumm, and IgG >150IU/ml
OR presence of 22,25, or 69KD bands
in WBT.
26. Conclusion
Disease burden is high in India as
shown by seroprevalence studies.
There is no regulation for antenatal
screening
The rural population is highly
vulnerable but totally neglected
regarding testing for this important
pathogen .
Toxoplasmosis remains a neglected
disease in India.